Improved blood sugar control may also benefit people with conditions like polycystic ovary syndrome (PCOS), which is associated with insulin resistance
Other common gastrointestinal effects include: Vomiting (5-24% of patients) Diarrhea (8-30% of patients) Constipation (10-24% of patients) Abdominal pain or discomfort (5-20% of patients) These side effects are typically most pronounced when initiating therapy or increasing doses, and often diminish over time as the body adjusts to the medication
GLP-3 is not the formal name of one single FDA-approved medication
What are the differences between Melanotan 2 and PT-141
However, evidence is still emerging, and further well-designed randomized controlled trials are needed to develop the most effective and safe nutritional strategies for patients with FM
More broadly, they challenge the traditional separation between metabolic and psychiatric disease, suggesting peripheral metabolic signals can influence central processes such as motivation and behavior